ºÝºÝߣ

ºÝºÝߣShare a Scribd company logo

Creative Solutions to Launching & Funding Early Stage Bioscience Companies in the New Economy

•Download as PPT, PDF•
•
B
Boltonhillconsulting

Speakers who will present at this TCM/Bio Breakfast event organized by Bolton Hill Consulting and co-hosted by GBC & GBTC and sponsored by Arcion Therapeutics, Martek, VWR, and the University of Maryland BioPark. UMB BioPark Life Sciences Conference Center First Floor 801 West Baltimore St Baltimore, MD 21201 4/16/09 7:30-10:30 am In today’s economic environment, more so than at any other time, it is imperative for emerging and early-stage companies to be able to identify and access both traditional and non-traditional sources of capital. What are some of the creative funding strategies that Maryland-based entrepreneurs have successfully used to keep their products and projects moving through development? Hear from our panel of funding specialists representing foundations, angel investment groups, venture capital firms, and the State government as they describe their programs and the resources available to help fledgling businesses. In addition, a group of well-respected local bioscience entrepreneurs will share their first-hand experiences in overcoming the challenges posed by today’s financial crisis. Join us for an informative and interactive discussion. Our speakers include: Paul Silber, Ph.D. (moderator) Director, Evergreen Capital Former CEO, InVitro Technologies Delegate Dan Morhaim, M.D. Deputy Majority Leader Maryland House of Delegates Margaret A. Anderson Chief Operating Officer FasterCures Youseph Yazdi, Ph.D. Corporate Director, Corporate Office of Science and Technology Johnson and Johnson Registration link: https://techcouncilmd.com/events/register.php

1 of 14
Download to read offline
Creative Solutions to Launching & Funding Early Stage Bioscience Companies in the New Economy April 16, 2009 7:30-10:30 AM University of Maryland BioPark Building Two 801 W. Baltimore Street, Baltimore, MD 21201
Halima Aquino, MA Principal, Bolton Hill Consulting, Ltd. Founded Bolton Hill Consulting, Ltd, 2008 to develop innovative communication strategies for science based entrepreneurs in aerospace, bioscience & healthcare: Provides strategic community outreach & collaborative partnership planning in the industry, education & government environments. Provides strategic communications through social networking, event planning, speaking engagement planning & focus groups. Founded & Launched LilyPad Sensors Corporation in 2006. Former Director of Internal Services & Commuications, Martek Biosciences Former Industry Strategy Manager, Maryland Governor’s Workforce Investment Board & Baltimore Mayor’s Workforce Investment Board Master’s Level Psychologist with clinical research, program management, interviewing, group facilitation, & psychological testing skills. Academics: ACTiVATE Technology Entrepreneurship Training, UMBC, M.A. Clinical Psychology (All but Dissertation), University of Maryland & B.A., International Relations & French, College of Wooster. Member & Volunteer: Emerging Companies Roundtable, GBTC, MDBioProgram Planning Committee, MIT Enterprise Forum of DC, Maryland Women in Technology & the Global Women’s Technology Collaborative
James N Campbell, MD President & CEO, Arcion Therapeutics Inc. & Executive in Residence, InterWest Partners Director of InterWest portfolio companies Anesiva & Amplimmune Founder, President & CEO of Arcion Therapeutics Inc. a venture-backed company focused on the development of targeted therapies for chronic pain. Founder & Chairman Emeritus, American Pain Foundation. Professor of Neurosurgery & Director of the Blaustein Pain Treatment Center School of Medicine , JHU Authored several books, & 100 peer-reviewed research papers. National awards for research & public service, including: Jacob Javits Neuroscience Investigator Award, NIH Grass Award, Society of Neurological Surgery Kerr Award for Research, American Pain Society M.D.,Yale Univ., Residency in Neurosurgery, JHU & Post-doctoral training in Neurophysiology, JHU. B.A., Univ. of Michigan Diplomate, American Board of Neurological Surgery
Paul Silber, Ph.D. Principal, Silber & Associates & Director, Evergreen Capital Former President/CEO & Founder, In Vitro Technologies, Inc. (IVT), a bioscience company that provided products & services to pharmaceutical & biotechnology companies. Grew company to 60 employees & $11M in revenues without venture capital Successfully sold the company to Celsis plc in 2006 for $30M. Received these business awards among others: MD Entrepreneur of the Year Award (High Technology) GBTC Beta Award Washington Techway’s to p 10 Bosses GBC Leadership in Bioscience Award State of Maryland’s International Leadership Award Board Membership: Chair, GBTC Biotech Roundtable, Biotechnical Institute of Maryland, TechCenter at UMBC Business Advisor & Dean’s Advisory, UMBC College of Natural Sciences. Ph.D. in Pharmacology & Toxicology, Univ. Arizona, Master's degree in Public Health, Univ. Alabama & B.S. in Biology, Carleton College
Dan K. Morhaim, M.D. Member, Maryland House of Delegates Only physician in the Maryland House of Delegates Focuses on health care, the environment, & streamlining government operations Deputy Majority Leader, serves on the Health & Government Operations Committee Chairs the sub-committee on Government Operations. House Chair of the Joint Committee on Health Care Delivery & Finance. Chair, Legislative Biotech Caucus (founded 1st biotechnology caucus) Board-Certified, Internal Medicine & Emergency Medicine. Founding Chair, Emergency Medicine, Franklin Square Hospital On staff at Sinai, Northwest, & the Health Care for the Homeless & on faculty, JHH School of Public Health Serves on the Board of UMBI
James A. Poulos, III, J.D. VP of Technology Transfer & Commercialization Maryland TEDCO At TEDCO: Oversees tech transfer funding program, including Maryland Technology Transfer Fund Is creating an angel network for TEDCO Portfolio companies. Former Executive & Acting Director, Office of Tech Commercialization, UMCP 1998-2000 Managed US patent portfolio at Zambon Group S.p.A. (Zambon). Since 1980: written over 150 patent applications & prosecuted at > 1,000 applications.  Former adjunct faculty member of UB’s Merrick School Of Business.   B.S Chemistry, UMCP, 1979, J.D, UB, 1984   Membership in ABA, AIPLA, MPLA, AUTM, LES                          
Lawrence Mahan, PhD Acting Executive Director Maryland Biotechnology Center As acting Executive Director for MBC, showcases & supports biotechnology innovation & entrepreneurship in Maryland. Joined DBED in 2001 as Senior Strategic Advisor for Biosciences to DBED & the Governor Oversees programs of business development, strategic partnering, & industry initiatives in one of the largest clusters of bioscience companies & federal research laboratories in the United States. 10 years in the U.S. DHHS as Senior Scientist Author of over 100 published articles & abstracts Holds 4 US patents: biology, functional genomics, neuroscience, pharmacology, immunology & biochemistry . Ph.D., University of California, San Diego, California & Post Doctoral Training, (NIH).
Youseph Yazdi, PhD, MBA Corporate Director Corporate Office of Science & Technology Johnson & Johnson At COSAT responsible for building Johnson & Johnson's open innovation network to nurture health care innovation. Member of several task forces, including: Energy-Based Therapeutics, RFID, Urology & Sexual Health, Neuroregeneration/Neuromodulation, Medical Optics, & MEMS & Nanotechnology. Ph.D., Biomedical Engineering, In Optical Spectroscopy, University of Texas at Austin., MS, in the detection of malignancy associated changes in breast & cervical cells, UTA, BS in Electrical & Computer Engineering, Rice University, & MBA, Wharton School Fellow, American Institute for Medical & Biological Engineering Advisory Board Member: University of Michigan, the University of Virginia, Drexel University, Georgia Tech, Boston University, & the Wallace H. Coulter Foundation Investment Advisory Board Member: Virginia Center for Innovative Technology & Maryland Technology Development Corporation
Margaret Anderson, M.A. Chief Operating Officer, FasterCures Former Deputy Director & Team Leader for the Center on AIDS & Community Health Educational Development (AED) in Washington, D.C Former Program Director for the Society for Women’s Health Research. Former Health Science Analyst at the American Public Health Association working on a portfolio of public health issues. Former analyst & project director at the Congressional Office of Technology Assessment working on studies requested by Congressional committees related to the use of genetic testing in a variety of settings. Serves as a member of the Whitman Walker Clinic Institutional Review Board in Washington, DC. MA in Science, technology & public policy from GWU Elliott School of International Affairs
Matt Zuga, M.B.A. Founder & Managing Director Red Abbey Venture Partners Responsible for managing all of Red Abbey’s investments, Including 24 companies: 15 privately held & 9 publicly traded. Current member of the Board of Directors of Arginetix, Inc. Current BOD observer at Advanced BioHealing & Alba Therapeutics Corporation & Former BOD observer, Sirtris Pharmaceuticals (prior to IPO). Former Managing Director in the investment banking department of Legg Mason Wood Walker, Inc. & Head of the Life Sciences Group. Prior work experience includes: Raymond James & Associates, Inc. (investment banking), Southeast Bank, N.A. (commercial lending), IBM Corporation (finance department) & GMC Corporation (industrial engineering). MBA, Kenan-Flagler Business School, UNC at Chapel Hill, 1993 & BS, OSU, 1988
Elizabeth Good, M.S. Director, Strategic Investments University of Maryland, Baltimore Former Managing Director, Maryland Venture Fund Managed a portfolio of 85 life science & IT companies, plus 9 venture capital LP investments (>$40 million in investment) Represented the State as advisor &/or BOD observer at 15+ bioscience portfolio companies, including A&G Pharmaceuticals, Advanced BioNutrition, Chesapeake PERL, Cylex, Cytimmune Sciences, Innovative Biosensors, etc. Former product development engineer for 2 venture-backed point-of-care cardiovascular diagnostic companies: Accumetrics provides industry-leading diagnostic tests for platelet function assessment. Automedics was acquired by Gensia Pharmaceuticals. Committee Work includes: DBED Transition Team Sub-Committees on Venture Capital, Maryland Life Sciences Advisory Board & SBIR review panels M.S. in Bioengineering, UCSD & B.S. in Biomedical & Electrical Engineering, Duke University
Ravinder Dhallan, M.D./Ph.D. M.B.A . Founder, Chairman & CEO, Ravgen Founded Ravgen in September of 2000 & Invented Ravgen's proprietary technology. Provided leadership for Ravgen's business strategy Extensive & diverse training in biomedical engineering, clinical research, & medicine Published numerous articles on genetic research in widely recognized & internationally accepted peer-reviewed journals. A residency-trained, board-certified emergency room physician. M.D. & Ph.D. (Biomedical Engineering), JHU School of Medicine & MBA from The Wharton School of Business, UPenn.
Kris Appel, M.A. President & CEO, Encore Path, Inc. VP of US Operations for e4e, a global technology services company managing over 500 employees in 3 locations Spent 17 years at the NSA roles included:Internal Communications Director for the Director of NSA & Senior Director of Operations Policy MA in Romance Linguistics, University of Michigan, 2006 graduate of the ACTiVATE technology entrepreneurship program at UMBC. 1st place winner of two business plan competitions Founder of the Apple Harvest Giving Circle, raising funds for educational & health-related charities.
Ginette Serrero, Ph.D. Co-Founder & CEO A&G Pharmaceuticals Internationally recognized scientist for her work on adipocyte differentiation & breast cancer. > 80 published papers & inventor on 8 issued patents (US & International) & 14 recently filed patents. Current Adjunct Professor of Pharmaceutical Sciences & Pathology, UM Cancer Center & Former Full Professor, Pharma Sciences, Oncology, UM School of Pharmacy & Greenebaum Cancer Center. In Academia, Dr. Serrero received: > $ 5 million grant awards : including NIH, DOD, Juvenile Diabetes Foundation, AHA, & the Susan G. Komen Breast Cancer Foundation PhD, Biochemistry, D. Sc, Cell Biology, University of Marseille & Nice in France & Post-doctoral fellow, UCSD with Dr. Gordon Sato

More Related Content

Creative Solutions to Launching & Funding Early Stage Bioscience Companies in the New Economy

  • 1. Creative Solutions to Launching & Funding Early Stage Bioscience Companies in the New Economy April 16, 2009 7:30-10:30 AM University of Maryland BioPark Building Two 801 W. Baltimore Street, Baltimore, MD 21201
  • 2. Halima Aquino, MA Principal, Bolton Hill Consulting, Ltd. Founded Bolton Hill Consulting, Ltd, 2008 to develop innovative communication strategies for science based entrepreneurs in aerospace, bioscience & healthcare: Provides strategic community outreach & collaborative partnership planning in the industry, education & government environments. Provides strategic communications through social networking, event planning, speaking engagement planning & focus groups. Founded & Launched LilyPad Sensors Corporation in 2006. Former Director of Internal Services & Commuications, Martek Biosciences Former Industry Strategy Manager, Maryland Governor’s Workforce Investment Board & Baltimore Mayor’s Workforce Investment Board Master’s Level Psychologist with clinical research, program management, interviewing, group facilitation, & psychological testing skills. Academics: ACTiVATE Technology Entrepreneurship Training, UMBC, M.A. Clinical Psychology (All but Dissertation), University of Maryland & B.A., International Relations & French, College of Wooster. Member & Volunteer: Emerging Companies Roundtable, GBTC, MDBioProgram Planning Committee, MIT Enterprise Forum of DC, Maryland Women in Technology & the Global Women’s Technology Collaborative
  • 3. James N Campbell, MD President & CEO, Arcion Therapeutics Inc. & Executive in Residence, InterWest Partners Director of InterWest portfolio companies Anesiva & Amplimmune Founder, President & CEO of Arcion Therapeutics Inc. a venture-backed company focused on the development of targeted therapies for chronic pain. Founder & Chairman Emeritus, American Pain Foundation. Professor of Neurosurgery & Director of the Blaustein Pain Treatment Center School of Medicine , JHU Authored several books, & 100 peer-reviewed research papers. National awards for research & public service, including: Jacob Javits Neuroscience Investigator Award, NIH Grass Award, Society of Neurological Surgery Kerr Award for Research, American Pain Society M.D.,Yale Univ., Residency in Neurosurgery, JHU & Post-doctoral training in Neurophysiology, JHU. B.A., Univ. of Michigan Diplomate, American Board of Neurological Surgery
  • 4. Paul Silber, Ph.D. Principal, Silber & Associates & Director, Evergreen Capital Former President/CEO & Founder, In Vitro Technologies, Inc. (IVT), a bioscience company that provided products & services to pharmaceutical & biotechnology companies. Grew company to 60 employees & $11M in revenues without venture capital Successfully sold the company to Celsis plc in 2006 for $30M. Received these business awards among others: MD Entrepreneur of the Year Award (High Technology) GBTC Beta Award Washington Techway’s to p 10 Bosses GBC Leadership in Bioscience Award State of Maryland’s International Leadership Award Board Membership: Chair, GBTC Biotech Roundtable, Biotechnical Institute of Maryland, TechCenter at UMBC Business Advisor & Dean’s Advisory, UMBC College of Natural Sciences. Ph.D. in Pharmacology & Toxicology, Univ. Arizona, Master's degree in Public Health, Univ. Alabama & B.S. in Biology, Carleton College
  • 5. Dan K. Morhaim, M.D. Member, Maryland House of Delegates Only physician in the Maryland House of Delegates Focuses on health care, the environment, & streamlining government operations Deputy Majority Leader, serves on the Health & Government Operations Committee Chairs the sub-committee on Government Operations. House Chair of the Joint Committee on Health Care Delivery & Finance. Chair, Legislative Biotech Caucus (founded 1st biotechnology caucus) Board-Certified, Internal Medicine & Emergency Medicine. Founding Chair, Emergency Medicine, Franklin Square Hospital On staff at Sinai, Northwest, & the Health Care for the Homeless & on faculty, JHH School of Public Health Serves on the Board of UMBI
  • 6. James A. Poulos, III, J.D. VP of Technology Transfer & Commercialization Maryland TEDCO At TEDCO: Oversees tech transfer funding program, including Maryland Technology Transfer Fund Is creating an angel network for TEDCO Portfolio companies. Former Executive & Acting Director, Office of Tech Commercialization, UMCP 1998-2000 Managed US patent portfolio at Zambon Group S.p.A. (Zambon). Since 1980: written over 150 patent applications & prosecuted at > 1,000 applications.  Former adjunct faculty member of UB’s Merrick School Of Business.   B.S Chemistry, UMCP, 1979, J.D, UB, 1984   Membership in ABA, AIPLA, MPLA, AUTM, LES                          
  • 7. Lawrence Mahan, PhD Acting Executive Director Maryland Biotechnology Center As acting Executive Director for MBC, showcases & supports biotechnology innovation & entrepreneurship in Maryland. Joined DBED in 2001 as Senior Strategic Advisor for Biosciences to DBED & the Governor Oversees programs of business development, strategic partnering, & industry initiatives in one of the largest clusters of bioscience companies & federal research laboratories in the United States. 10 years in the U.S. DHHS as Senior Scientist Author of over 100 published articles & abstracts Holds 4 US patents: biology, functional genomics, neuroscience, pharmacology, immunology & biochemistry . Ph.D., University of California, San Diego, California & Post Doctoral Training, (NIH).
  • 8. Youseph Yazdi, PhD, MBA Corporate Director Corporate Office of Science & Technology Johnson & Johnson At COSAT responsible for building Johnson & Johnson's open innovation network to nurture health care innovation. Member of several task forces, including: Energy-Based Therapeutics, RFID, Urology & Sexual Health, Neuroregeneration/Neuromodulation, Medical Optics, & MEMS & Nanotechnology. Ph.D., Biomedical Engineering, In Optical Spectroscopy, University of Texas at Austin., MS, in the detection of malignancy associated changes in breast & cervical cells, UTA, BS in Electrical & Computer Engineering, Rice University, & MBA, Wharton School Fellow, American Institute for Medical & Biological Engineering Advisory Board Member: University of Michigan, the University of Virginia, Drexel University, Georgia Tech, Boston University, & the Wallace H. Coulter Foundation Investment Advisory Board Member: Virginia Center for Innovative Technology & Maryland Technology Development Corporation
  • 9. Margaret Anderson, M.A. Chief Operating Officer, FasterCures Former Deputy Director & Team Leader for the Center on AIDS & Community Health Educational Development (AED) in Washington, D.C Former Program Director for the Society for Women’s Health Research. Former Health Science Analyst at the American Public Health Association working on a portfolio of public health issues. Former analyst & project director at the Congressional Office of Technology Assessment working on studies requested by Congressional committees related to the use of genetic testing in a variety of settings. Serves as a member of the Whitman Walker Clinic Institutional Review Board in Washington, DC. MA in Science, technology & public policy from GWU Elliott School of International Affairs
  • 10. Matt Zuga, M.B.A. Founder & Managing Director Red Abbey Venture Partners Responsible for managing all of Red Abbey’s investments, Including 24 companies: 15 privately held & 9 publicly traded. Current member of the Board of Directors of Arginetix, Inc. Current BOD observer at Advanced BioHealing & Alba Therapeutics Corporation & Former BOD observer, Sirtris Pharmaceuticals (prior to IPO). Former Managing Director in the investment banking department of Legg Mason Wood Walker, Inc. & Head of the Life Sciences Group. Prior work experience includes: Raymond James & Associates, Inc. (investment banking), Southeast Bank, N.A. (commercial lending), IBM Corporation (finance department) & GMC Corporation (industrial engineering). MBA, Kenan-Flagler Business School, UNC at Chapel Hill, 1993 & BS, OSU, 1988
  • 11. Elizabeth Good, M.S. Director, Strategic Investments University of Maryland, Baltimore Former Managing Director, Maryland Venture Fund Managed a portfolio of 85 life science & IT companies, plus 9 venture capital LP investments (>$40 million in investment) Represented the State as advisor &/or BOD observer at 15+ bioscience portfolio companies, including A&G Pharmaceuticals, Advanced BioNutrition, Chesapeake PERL, Cylex, Cytimmune Sciences, Innovative Biosensors, etc. Former product development engineer for 2 venture-backed point-of-care cardiovascular diagnostic companies: Accumetrics provides industry-leading diagnostic tests for platelet function assessment. Automedics was acquired by Gensia Pharmaceuticals. Committee Work includes: DBED Transition Team Sub-Committees on Venture Capital, Maryland Life Sciences Advisory Board & SBIR review panels M.S. in Bioengineering, UCSD & B.S. in Biomedical & Electrical Engineering, Duke University
  • 12. Ravinder Dhallan, M.D./Ph.D. M.B.A . Founder, Chairman & CEO, Ravgen Founded Ravgen in September of 2000 & Invented Ravgen's proprietary technology. Provided leadership for Ravgen's business strategy Extensive & diverse training in biomedical engineering, clinical research, & medicine Published numerous articles on genetic research in widely recognized & internationally accepted peer-reviewed journals. A residency-trained, board-certified emergency room physician. M.D. & Ph.D. (Biomedical Engineering), JHU School of Medicine & MBA from The Wharton School of Business, UPenn.
  • 13. Kris Appel, M.A. President & CEO, Encore Path, Inc. VP of US Operations for e4e, a global technology services company managing over 500 employees in 3 locations Spent 17 years at the NSA roles included:Internal Communications Director for the Director of NSA & Senior Director of Operations Policy MA in Romance Linguistics, University of Michigan, 2006 graduate of the ACTiVATE technology entrepreneurship program at UMBC. 1st place winner of two business plan competitions Founder of the Apple Harvest Giving Circle, raising funds for educational & health-related charities.
  • 14. Ginette Serrero, Ph.D. Co-Founder & CEO A&G Pharmaceuticals Internationally recognized scientist for her work on adipocyte differentiation & breast cancer. > 80 published papers & inventor on 8 issued patents (US & International) & 14 recently filed patents. Current Adjunct Professor of Pharmaceutical Sciences & Pathology, UM Cancer Center & Former Full Professor, Pharma Sciences, Oncology, UM School of Pharmacy & Greenebaum Cancer Center. In Academia, Dr. Serrero received: > $ 5 million grant awards : including NIH, DOD, Juvenile Diabetes Foundation, AHA, & the Susan G. Komen Breast Cancer Foundation PhD, Biochemistry, D. Sc, Cell Biology, University of Marseille & Nice in France & Post-doctoral fellow, UCSD with Dr. Gordon Sato